After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Cytek BioSciences Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Medical Devices industry. The current market capitalization of Cytek BioSciences Inc is $708.84M. A total of 0.63 million shares were traded on the day, compared to an average of 701.74K shares.
In the most recent transaction, Yan Ming sold 20,000 shares of CTKB for 5.87 per share on Apr 19 ’24. After the transaction, the CHIEF TECHNOLOGY OFFICER now owns 5,988,502 company shares. In a previous transaction on Apr 09 ’24, Yan Ming sold 1,900 shares at 7.00 per share. CTKB shares that CHIEF TECHNOLOGY OFFICER owns now total 6,008,502.
Among the insiders who sold shares, Yan Ming disposed of 20,000 shares on Mar 18 ’24 at a per-share price of $6.77. This resulted in the CHIEF TECHNOLOGY OFFICER holding 6,030,402 shares of CTKB after the transaction. In another insider transaction, Yan Ming sold 20,000 shares at $6.71 per share on Mar 19 ’24. Company shares held by the CHIEF TECHNOLOGY OFFICER now total 6,010,402.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, CTKB has a high of $9.87 and a low of $3.80.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. CTKB’s latest balance sheet shows that the firm has $364.62M in Cash & Short Term Investments as of fiscal 2021. There were $0.00 in debt and $33.18M in liabilities at the time. Its Book Value Per Share was $2.96, while its Total Shareholder’s Equity was $405.38M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CTKB is Buy with a score of 4.33.
